ZINC (Hospira, Inc.)
Welcome to the PulseAid listing for the ZINC drug offered from Hospira, Inc.. This Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | ZINC CHLORIDE |
SUBSTANCE NAME: | ZINC CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1990-09-30 |
END MARKETING DATE: | 0000-00-00 |
ZINC HUMAN PRESCRIPTION DRUG Details:
Item Description | ZINC from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 1990-09-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-4090_c6418e26-4e62-49bc-b3c8-f027e5815bc4 |
PRODUCT NDC: | 0409-4090 |
APPLICATION NUMBER: | NDA018959 |
Other ZINC CHLORIDE Pharmaceutical Manufacturers / Labelers: